| Sarah Opperman, | |
|
9669 E 146th St Ste 250, Noblesville, IN 46060-5006 | |
| (317) 621-9076 | |
| Not Available |
| Full Name | Sarah Opperman |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Ambulatory Care |
| Location | 9669 E 146th St Ste 250, Noblesville, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003594441 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P2201X | Pharmacist - Ambulatory Care | 26029798A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Opperman, 9669 E 146th St Ste 250, Noblesville, IN 46060-5006 Ph: () - | Sarah Opperman, 9669 E 146th St Ste 250, Noblesville, IN 46060-5006 Ph: (317) 621-9076 |
News Archive
Researchers at UT Southwestern Medical Center have determined that light reflectance spectroscopy can differentiate between malignant and benign prostate tissue with 85 percent accuracy, a finding that may lead to real-time tissue analysis during prostate cancer surgery.
Instead of a cloak of invisibility hiding a person in television and movies, a new method that describes mounting many imaging sensors underneath a flexible substrate could reveal tumors within humans or animals.
Nighttime noise from nearby road traffic, passing trains and overhead planes disturbs sleep and impairs morning performance, according to a research abstract that will be presented Tuesday, June 8, 2010, in San Antonio, Texas, at SLEEP 2010, the 24th annual meeting of the Associated Professional Sleep Societies LLC.
Brain cells exposed to a form of the amyloid beta protein, the molecule linked to Alzheimer's disease, become stiffer and bend less under pressure, researchers at UC Davis have found. The results reveal one mechanism by which the amyloid protein damages the brain, a finding that could lead to new ways to screen drugs for Alzheimer's and similar diseases.
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that it has enrolled the first patients in Phase III clinical trials for its autism treatment, CM-AT. The first clinical trial patients have been enrolled at Lake Mary Pediatrics in Orange City, Florida, one of 12 clinical trial sites with a total 170 children across the country.
› Verified 4 days ago
Mrs. Stephani Lyn Hedrick, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 555 Westfield Rd, Noblesville, IN 46060 Phone: 317-774-8346 | |
Taylor Hibner, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9669 E 146th St, Noblesville, IN 46060 Phone: 317-621-9346 | |
Marianne Abdelmessih, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14835 Sunny Dell Ln, Noblesville, IN 46062 Phone: 317-569-1392 | |
Jennifer Lynne Niehoff, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9669 E 146th St, Noblesville, IN 46060 Phone: 317-621-9346 | |
Angela Bergstedt, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14450 Getz Rd, Noblesville, IN 46060 Phone: 317-818-1059 | |
Kelli Collett, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13085 Tegler Dr, Noblesville, IN 46060 Phone: 317-770-7089 Fax: 317-770-7232 |